Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

uCAIR

Financiado

Cerrado

ULTRA FAST CHEMICAL ANALYSIS IMAGING WITH RAMAN

Most diseases including cancers, viral infections, neurodegenerative conditions, cardiovascular and musculoskeletal disorders, all originate from a molecular level disruption of the biological cell lifecycle. Each year the cost to... ver más

30/06/2027

Líder desconocido

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto Líder desconocido

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-20

HORIZON-CL4-2023-DIGITAL-EMERGING-01-12: Adaptive multi-scale modelling and... ExpectedOutcome:Projects are expected to contribute to the following outcomes:

I+D

Cerrada

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

LAMBDA-X HIGH TECH

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 43 meses Fecha Inicio: 2023-11-20
Fecha Fin: 2027-06-30

Líder del proyecto Líder desconocido

Presupuesto del proyecto 5M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Most diseases including cancers, viral infections, neurodegenerative conditions, cardiovascular and musculoskeletal disorders, all originate from a molecular level disruption of the biological cell lifecycle. Each year the cost to the EU is ca. 1.9 million lives and ca. €200 billion in health care, informal care and productivity loss for cancers alone. Current live cell imaging tools can only provide a limited view of the in vivo and in vitro microenvironments where diseases originate and grow. The result is a gap in our understanding of the biochemical cellular makeup and how their disturbance leads to disease. By increasing accuracy and speed of imaging and analysis, the gap can be closed allowing novel medical treatments and diagnostics tailored to patients’ specific conditions. uCAIR brings successful R&D photonics SMEs, research laboratories in optics and cell biology, and world-leading microscopists and clinicians to create an innovative, versatile, practical multimodal photonics platform that will enhance and speed up the way cells are examined by scientists and healthcare professionals. uCAIR will achieve breakthrough results by developing a laser platform that inventively combines non-linear optical fibers, optronics, wide-band coherent Raman and artificial intelligence technologies to image at video rates and track cells and biological tissues with augmented chemometric digitalisation. The new coherent light sources will be suitable for fundamental research microscopes and microfluidic channels but also in medical imaging instruments, encompassing a value chain for new biomarker discoveries and translation into medical endoscopy, for example during cystoscopy and resection of bladder cancer. Technology progression to TRL 6 will allow first mover advantage with sustainable supply chain. In this way, uCAIR sustains the European leadership in photonics to deliver continuous innovation and outstanding benefits for its economy and the health of its population.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores